Biomedical company Tissue Analytics has developed AI-powered solutions for automated mobile wound and skin imaging and predictive analytics. The system enhances the common smartphone with proprietary technology to turn it into an imaging platform designed to support clinicians with wound care and improve patient outcomes.
In May 2020, Net Health, a provider of cloud-based Electronic Health Record (EHR) software for specialized care settings, acquired Tissue Analytics to expand its position in the wound care market.
Tissue Analytics seed investors shared in the liquidity event when Net Health acquired Tissue Analytics for an undisclosed sum.
If you are interested in building your portfolio by adding investments in startups, you can find more information here on how to start angel investing and how to find opportunities for angel investing on the Propel(x) platform.
This article is for informational purposes only. We do not provide legal, financial, or tax advice and investors should consult their advisors prior to making any investment. As with any investment, past performance is no guarantee of future performance, and any investment decision must balance the risk against the potential return. Private investments are highly illiquid and risky and are not suitable for all investors. There is no guarantee that a liquidity event will ever take place.
This article contains links to third-party websites. These links are provided solely as a convenience to you and do not imply an affiliation, sponsorship, endorsement, approval, investigation, verification, or monitoring by us of the contents on such third-party websites. We are not responsible for the content of any website owned by a third party and do not guarantee the accuracy, timeliness, completeness, suitability, reliability, or usefulness of any information.